ALT Quote card of NIHR CEO Prof Lucy Chappell saying "By backing these 6 digital research projects, the NIHR is helping to drive the fundamental shift from an analogue to a digital health service and deliver the government’s 10-year health plan. “This important investment in AI and innovation will cut NHS waiting times, fast-tracking diagnoses and ensuring patients receive more accessible, efficient, and high-quality care."

ALT A graphic with a blue star in the top left-hand corner with "400" written in it, and the words "participants recruited" next to it. In the top right-hand corner is the SAFE-D study logo, a lighthouse with a strand of DNA coming out of the light. At the bottom are the Southampton Clinical Trials Unit, ClearNote Health, Cancer Research UK and University Hospital Southampton NHS Foundation Trust logos.

ALT A graphic with a white a purple background. On the left is a round photo of Sam Wilding, Senior Statistician for the SAFE-D trial, with a purple surround, and on the right is the quote "There are few blood tests for pancreatic cancer available that have rigorous scientific evidence.  The data behind the Avantect Pancreatic Cancer Test is very promising, and if the SAFE-D study shows that it works well in a real-world scenario then this can transform the outlook for pancreatic cancer. I'm most proud of being part of the SAFE-D team and our aim to revolutionise the pancreatic cancer diagnosis journey." Underneath the quote are the social media hashtags #PurpleForPancreaticCancer, #PancreaticCancerAwarenessMonth, and #MostProudOf in purple writing. On the bottom left are the Southampton Clinical Trials Unit, University Hospital Southampton, University of Southampton, and Clearnote Health logos.

ALT A graphic with a white a purple background. On the left is a round photo of Oli Seymour, Data Manager for the SAFE-D trial, with a purple surround, and on the right is the quote "This team is evaluating an early detection test for pancreatic cancer in newly diagnosed type 2 diabetes patients (an indicator for pancreatic cancer). What makes me proud is being part of such an incredible, hardworking nationwide team that has been chosen to evaluate this cutting-edge method for our fight against pancreatic cancer, hopefully culminating in successful outcomes in early detection for our patients". Underneath the quote are the social media hashtags #PurpleForPancreaticCancer, #PancreaticCancerAwarenessMonth, and #MostProudOf in purple writing. On the bottom left are the Southampton Clinical Trials Unit, University Hospital Southampton, University of Southampton, and Clearnote Health logos.

ALT A graphic with a white a purple background. On the left is a round photo of Mr Zaed Hamady, Chief Investigator of the SAFE-D trial, with a purple surround, and on the right is the quote "Improving the early diagnosis of pancreatic cancer is vital. If we can develop approaches to detect the cancer sooner, then there are more options we may consider to treat the disease, and patients will have a much better chance of long-term survival. I’m proud to be part of the SAFE-D team, helping make early diagnosis a reality for more patients.". Underneath the quote are the social media hashtags #PurpleForPancreaticCancer, #PancreaticCancerAwarenessMonth, and #MostProudOf in purple writing. On the bottom left are the Southampton Clinical Trials Unit, University Hospital Southampton, University of Southampton, and Clearnote Health logos.

ALT A group of researchers and clinical trialists in a research building, wearing purple, holding purple cupcakes and cheering.